Johnson & Johnson fined $1.1bn in Risperdal case

AN Arkansas judge fined Johnson & Johnson and a subsidiary more than $US1.1 billion ($1.07 billion) today for downplaying and concealing risks associated with the anti-psychotic drug Risperdal.

http://www.news.com.au/business/breaking-news/johnson-johnson-fined-11bn-in-risperdal-case/story-e6frfkur-1226324609466

Go Back

© 2016 Humane Research Australia (ABN 17 208 630 818)  Terms & Conditions